[HTML][HTML] Comparisons of clinical features and outcomes of COVID-19 between patients with pediatric onset inflammatory rheumatic diseases and healthy children
…, A Adrovic, S Sahin, G Kes, A Ayzit-Kilinc… - Journal of Clinical …, 2022 - mdpi.com
(1) Background: We aimed to describe the clinical features and outcomes of coronavirus
disease-2019 (COVID-19) in children and late adolescents with inflammatory rheumatic …
disease-2019 (COVID-19) in children and late adolescents with inflammatory rheumatic …
The effect of training the health care providers with simulation model on the care of patients with chronic tracheostomy
…, EE Eralp, U Sivrikaya, S Girit, E Çakır, AA Kılıç… - 2021 - Eur Respiratory Soc
Introduction: Tracheostomy care in children may be challenging, due to lack of knowledge
of health care providers. The aim of this study was to determine the level of knowledge of …
of health care providers. The aim of this study was to determine the level of knowledge of …
Evaluation of respiratory function at 6 years of age in patients with cystic fibrosis with frequent pulmonary exacerbations in the first 2 years of life
…, Ş Çekiç, P Asfuroğlu, AT Aslan, K Harmancı, G Kılıç… - 2023 - Eur Respiratory Soc
Objectives-aim: Pulmonary exacerbations (PE) results in a progressive decline in pulmonary
function in patients with cystic fibrosis (CF). We aimed to evaluate the effects of acute PE …
function in patients with cystic fibrosis (CF). We aimed to evaluate the effects of acute PE …
Patients with cystic fibrosis who could not receive the CFTR modulator treatment: What did they lose in 1 year?
…, D Can, P Korkmaz Ekren, M Kılıç… - Pediatric …, 2023 - Wiley Online Library
Background Cystic fibrosis (CF) is an autosomal recessive disorder caused by CF transmembrane
conductance regulator (CFTR) genetic variants. CFTR modulators improve pulmonary …
conductance regulator (CFTR) genetic variants. CFTR modulators improve pulmonary …
Patients eligible for modulator drugs: Data from cystic fibrosis registry of Turkey
Background A better understanding of cystic fibrosis transmembrane conductance regulator
biology has led to the development of modulator drugs such as ivacaftor, lumacaftor‐…
biology has led to the development of modulator drugs such as ivacaftor, lumacaftor‐…
The ISPAT project: implementation of a standardized training program for caregivers of children with tracheostomy
…, S Uzuner, ZR Onay, A Kilic Baskan… - Pediatric …, 2022 - Wiley Online Library
… Cansu Yilmaz Yegit and Ayse Ayzit Kilinc contributed equally to this study. … Ayse Ayzit
Kilinc: data curation (equal); formal analysis (equal); investigation (equal); project administration (…
Kilinc: data curation (equal); formal analysis (equal); investigation (equal); project administration (…
Clinical findings of patients with cystic fibrosis according to newborn screening results
Background Cystic fibrosis (CF) is a lethal recessive genetic disease caused by loss of function
associated with mutations in the CF trans‐membrane conductance regulator. It is highly …
associated with mutations in the CF trans‐membrane conductance regulator. It is highly …
Clinical characteristics of patients requiring lung transplantation referral in national cystic fibrosis registry data
…, S Polat, A Ozdemir, K Harmanci, G Kilic… - Turkish Journal of …, 2023 - avesis.ankara.edu.tr
Background. We aimed to determine the number of cystic fibrosis (CF) patients recorded in
the Cystic Fibrosis Registry of Turkiye (CFRT) who were in need of lung transplantation (LT) …
the Cystic Fibrosis Registry of Turkiye (CFRT) who were in need of lung transplantation (LT) …
The effects of nusinersen treatment on respiratory status of children with spinal muscular atrophy
E Hepkaya, AA Kılınç Sakallı, İ Ülkersoy… - Pediatrics …, 2022 - Wiley Online Library
Background Respiratory involvement is the main factor predicting the prognosis of spinal
muscular atrophy (SMA). Significant responses in motor functions have been demonstrated …
muscular atrophy (SMA). Significant responses in motor functions have been demonstrated …
Childhood interstitial lung disease in Turkey: first data from the national registry
H Nayır-Büyükşahin, N Emiralioğlu, AA Kılınç… - European Journal of …, 2024 - Springer
The childhood interstitial lung diseases (chILD) Turkey registry (chILD-TR) was established
in November 2021 to increase awareness of disease, and in collaboration with the centers to …
in November 2021 to increase awareness of disease, and in collaboration with the centers to …